Sylvamo Set To Join S&P SmallCap 600, To Replace Stamps.com

https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20210928-1443805/1443805_slvm6.pdf

https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20210928-1443805/1443805_slvm6.pdf

Total
0
Shares
Related Posts
Read More

Regeneron Announced New U.S. Government Agreement to Purchase 1.4M Additional Doses of REGEN-COV Antibody Cocktail @$2,100/Dose

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Department of Health and Human Services (HHS) and the Department of Defense (DOD) will purchase 1.4 million additional doses of REGEN-COV (casirivimab and imdevimab). The government will continue to provide REGEN-COV at no cost to patients.

REGN